C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 3055-3061

  Singh, Ravinder J ^a   Taylor, Robert L ^a   Reddy, G Satyanarayana ^b   Grebe, Stefan K G ^a  

^a MAYO CLINIC   (United States)

^b Epimer LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COMPLEMENT COMPONENT C3;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; EPIMER; FEMALE; HEALTH STATUS; HUMAN; INFANT; LIQUID CHROMATOGRAPHY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY;

EID: 33747637729     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0710     Document Type: Article

References (36)

1. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439-443
2. Vieth R 1999 Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842-856
3. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501
4. Fairfield KM, Fletcher RH 2002 Vitamins for chronic disease prevention in adults: scientific review. JAMA 287:3116-3126
5. Zittermann A 2003 Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552-572
6. Hansen CM, Binderup L, Hamberg KJ, Carlberg C 2001 Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci 6:D820-48
7. Barragry JM, France MW, Corless D, Gupta SP, Switala S, Boucher BJ, Cohen RD 1978 Intestinal cholecalciferol absorption in the elderly and in younger adults. Clin Sci Mol Med 55:213-220
8. Barragry JM, France MW, Boucher BJ, Cohen RD 1979 Metabolism of intravenously administered cholecalciferol in man. Clin Endocrinol (Oxf) 11:491-495
9. Clemens TL, Zhou XY, Myles M, Endres D, Lindsay R 1986 Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab 63:656-660
10. Zerwekh JE 2004 The measurement of vitamin D: analytical aspects. Ann Clin Biochem 41:272-281
11. Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL, Sufi S 2004 Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 89-90:467-471
12. Hollis BW 2004 The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 89:3149-3151
13. Horst RL, Reinhardt TA, Beitz DC, Littledike ET 1981 A sensitive competitive protein binding assay for vitamin D in plasma. Steroids 37:581-591
14. Singh RJ, Taylor RL, Grebe SK, Advancements in the clinical methods for the analysis of 25 hydroxy vit-D resulting in improvements of patient care. Program of the 87th Annual Meeting of The Endocrine Society, San Diego, CA, 2005, p 450 (Abstract P2-386)
15. Taylor RL, Grebe SK, Singh RJ 2005 High throughput analysis of 25-hydroxyvitamins D2 and D3 by LC-MS/MS using an automated on-line extraction. Clin Chem 51(Suppl 6-05):A231-A232
16. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF, Drezner MK 2004 Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89:3152-3157
17. Bischof MG, Siu-Caldera ML, Weiskopf A, Vouros P, Cross HS, Peterlik M, Reddy GS 1998 Differentiation-related pathways of 1α,25- dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1α,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241:194-201
18. Siu-Caldera ML, Sekimoto H, Weiskopf A, Vouros P, Muralidharan KR, Okamura WH, Bishop J, Norman AW, Uskokovic MR, Schuster I, Reddy GS 1999 Production of 1α,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed. Bone 24:457-463
19. Sekimoto H, Siu-Caldera ML, Weiskopf A, Vouros P, Muralidharan KR, Okamura WH, Uskokovic MR, Reddy GS 1999 1α,25-Dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1α,25-dihydroxyvitamin D3 in rats. FEBS Lett 448:278-282
20. Kamao M, Tatematsu S, Sawada N, Sakaki T, Hatakeyama S, Kubodera N, Okano T 2004 Cell specificity and properties of the C-3 epimerization of vitamin D3 metabolites. J Steroid Biochem Mol Biol 89-90:39-42
21. Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, Ozono K, Kubodera N, Reddy GS, Okano T 2004 C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1α or C-24 hydroxylation. J Biol Chem 279:15897-15907
22. Brown AJ, Ritter C, Slatopolsky E, Muralidharan KR, Okamura WH, Reddy GS 1999 1α,25-Dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 73:106-113
23. Brown AJ, Ritter CS, Weiskopf AS, Vouros P, Sasso GJ, Uskokovic MR, Wang G, Reddy GS 2005 Isolation and identification of 1α-hydroxy-3-epivitamin D3, a potent suppressor of parathyroid hormone secretion. J Cell Biochem 96:569-578
24. 3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2). J Bone Miner Res 6:893-899
25. 3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro. Arch Biochem Biophys 329:228-234
26. Hollis BW, Napoli JL 1985 Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 31:1815-1819
27. 125I-labeled tracer. Clin Chem 39:529-533
28. Kamao M, Hatakeyama S, Sakaki T, Sawada N, Inouye K, Kubodera N, Reddy GS, Okano T 2005 Measurement and characterization of C-3 epimerization activity toward vitamin D3. Arch Biochem Biophys 436:196-205
29. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
30. 3: its production and metabolism in primary human keratinocytes. Mol Cell Endocrinol 170:91-101
31. 3 in neonatal human keratinocytes. Steroids 66:441-450
32. 3 retain biologic activity mediated through the vitamin D receptor. J Cell Biochem 78:112-120
33. 3 stimulate transcription through the vitamin D receptor. J Steroid Biochem Mol Biol 72:29-34
34. 2: evaluation of actions in bone. Steroids 66:347-355
35. 3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab 76:46-56
36. Carlberg C 2003 Molecular basis of selective activity of vitamin D analogs. J Cell Biochem 88:274-281